Consequently, we cannot exclude mechanism other that RvE1 such as that described by Luangsay et al. 31, who described that the ERV1/ChemR23 receptor mediates anti-inflammatory actions of chemerin in a lung disease model. Here, CMKLR1 is linked to lung disorder.